Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

Jonathan Scharfstein, MD

440.449.8890

Jonathan  Scharfstein, MD

Appointed: 2011

Jonathan Scharfstein, MD
Department: Cardiovascular Medicine
Location: Hillcrest Medical Building 2
Mail Code HCM-444
6801 Mayfield Road
Mayfield Heights, OH 44124
WorkAppointment:440.449.8890
WorkFax:440.449.7580
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Jonathan S. Scharfstein, MD, FACC, is a staff physician in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute. He practices at Hillcrest Hospital where he is Chief of the Division of Cardiology, Medical Director of the Coronary Care Unit and has been the Medical Director of the Chest Pain Center since 2007. He is board-certified in internal medicine, cardiovascular disease and interventional cardiology.

Prior to his appointment to the Cleveland Clinic staff, Dr. Scharfstein was in private practice with Cardiovascular Associates of Cleveland. He has been on the medical staff at Hillcrest since 2000. His previous positions include appointments at Brigham and Women’s and University Hospitals in Boston, Mass., Director of Interventional Cardiology and the cardiology fellowship training program at The Mt. Sinai Medical Center, Cleveland, and Co-Director of the cardiology fellowship training program at University Hospitals of Cleveland.

Dr. Scharfstein earned his undergraduate degree from Princeton University and his medical degree from the University of Pennsylvania School of Medicine. He served an internship and residency in medicine at The Johns Hopkins Hospital, Baltimore, Md. He completed fellowships in clinical cardiology and interventional cardiology at Brigham and Women’s Hospital, Boston, Mass., a research fellowship in medicine at Harvard University and a second fellowship in interventional cardiology at University Hospital, Boston.

In addition to his research fellowship at Harvard, which included teaching responsibilities, Dr. Scharfstein’s academic appointments have included clinical instructor positions at Harvard Medical School and Boston University School of Medicine. Since 1995 he has been an assistant professor of medicine at Case Western Reserve University School of Medicine in Cleveland.

Dr. Scharfstein has been an investigator on a number of significant clinical trials related to interventional strategies for heart attack and has published more than a dozen original papers, reviews and abstracts in professional journals.

He is a Fellow of the American College of Cardiology and a member of the Ohio Chapter of the American Heart Association. Dr. Scharfstein has been listed in Best Doctors in America since 2009.

 

 

Education & Fellowships

Fellowship - Boston Medical Center
Interventional Cardiology
Boston, MA USA
1994
Fellowship - Brigham & Women's Hospital
Cardiovascular Disease
Boston, MA
1993
Residency - Johns Hopkins Hospital
Internal Medicine
Baltimore, MD USA
1990
Medical School - University of Pennsylvania School of Medicine
Philadelphia, PA USA
1987
Undergraduate - Princeton University
Princeton, NJ USA
1983

Certifications

  • Internal Medicine
  • Internal Medicine- Cardiovascular Disease
  • Internal Medicine- Interventional Cardiology

Specialty Interests

Coronary artery disease, angina, heart valve disease, hyperlipidemia, chest pain

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/16/2014, Dr. Scharfstein has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English